Added to YB: 2024-01-23
Pitch date: 2024-01-22
ILMN [bullish]
Illumina, Inc.
-1.25%
current return
Author Info
No bio for this author
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$18.4B
Pitch Price
$136.58
Price Target
N/A
Dividend
N/A
EV/EBITDA
15.81
P/E
27.05
EV/Sales
4.60
Sector
Life Sciences Tools and Services
Category
turnaround
Illumina: One Of The Most Hated Stocks In Healthcare Is Looking Like A Strong Buy
$ILMN -70% from ATH plagued by neg headlines incl forced GRAIL divestiture, competition & biotech weakness but Q4 results strong on NovaSeq X launch. Genomics focus, China realignment, innovation & cost-cuts to drive growth. Analysts see recovery, EPS upswing, cheap P/E vs history - Strong Buy.
Read full article (6 min)